Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 4.46
- Piotroski Score 4.00
- Grade Buy
- Symbol (GERN)
- Company Geron Corporation
- Price $4.23
- Changes Percentage (-0.47%)
- Change -$0.02
- Day Low $4.12
- Day High $4.32
- Year High $5.34
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/06/2024
- Fiscal Year End N/A
- Average Stock Price Target $6.00
- High Stock Price Target $7.00
- Low Stock Price Target $4.50
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.34
- Trailing P/E Ratio -13.5
- Forward P/E Ratio -13.5
- P/E Growth -13.5
- Net Income $-184,127,000
Income Statement
Quarterly
Annual
Latest News of GERN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
World Series Champ Jack Flaherty Voices Eagerness To Stay With Dodgers
The Los Angeles Dodgers are poised to dominate baseball with a strong roster and financial flexibility, including Shohei Ohtani's contract. Pitcher Jack Flaherty expressed his desire to stay with the ...
By Newsweek | 3 days ago -
Apple's services unit is now a $100 billion a year juggernaut after 'phenomenal' growth
Apple's services division has reached $100 billion annually, with a 12% growth. This unit includes diverse offerings like AppleCare, iCloud, Apple TV+, and Apple Pay. Investors favor this segment due ...
By CNBC | 4 days ago -
Is Geron Corporation (GERN) the Best Growth Stock Under $10 to Buy?
A list of top growth stocks under $10 includes Geron Corporation (NASDAQ:GERN), a biopharmaceutical company focused on cancer therapies....
By Yahoo! Finance | 3 weeks ago
